DECITABINE

DECITABINE was reported 4367 times

DECITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TUMOUR CELL MOBILISATION 3 0.3000
1 GERM CELL NEOPLASM 4 0.1818
2 ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY POSITIVE 3 0.1765
3 DONOR LEUKOCYTE INFUSION 4 0.1538
4 CHIMERISM 11 0.1236
5 ACUTE MYELOID LEUKAEMIA REFRACTORY 19 0.1105
6 SEPTAL PANNICULITIS 5 0.0625
7 RADIATION FIBROSIS - LUNG 3 0.0484
8 LEPTOTRICHIA INFECTION 2 0.0444
9 AEROMONA INFECTION 2 0.0435
10 BLAST CELL COUNT DECREASED 3 0.0411
11 LEUKAEMIA CUTIS 6 0.0390
12 CLONAL EVOLUTION 4 0.0385
13 OVARIAN EPITHELIAL CANCER RECURRENT 2 0.0370
14 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 3 0.0370
15 ORAL LICHENOID REACTION 4 0.0367
16 STOMATOCOCCAL INFECTION 4 0.0323
17 MEGAKARYOCYTES DECREASED 3 0.0323
18 ALLOGENIC STEM CELL TRANSPLANTATION 5 0.0316
19 ACUTE MYELOID LEUKAEMIA RECURRENT 66 0.0307
20 LEUKAEMIC INFILTRATION 4 0.0286
21 MYELOBLAST COUNT INCREASED 2 0.0260
22 RED BLOOD CELL ELLIPTOCYTES PRESENT 2 0.0260
23 GEOTRICHUM INFECTION 5 0.0237
24 PANNICULITIS LOBULAR 2 0.0225
25 SPLENIC ABSCESS 9 0.0221
26 PERINEAL ULCERATION 3 0.0214
27 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 4 0.0202
28 IMAGING PROCEDURE ABNORMAL 2 0.0200
29 GRANULOCYTES ABNORMAL 4 0.0199
30 PARAINFLUENZA VIRUS INFECTION 2 0.0194
31 TOXIC ERYTHEMA OF CHEMOTHERAPY 5 0.0193
32 INTERSTITIAL LUNG ABNORMALITY 2 0.0175
33 LICHENIFICATION 7 0.0170
34 PENICILLIUM INFECTION 3 0.0167
35 CHRONIC MYELOMONOCYTIC LEUKAEMIA 11 0.0167
36 PHARYNGEAL HAEMATOMA 2 0.0165
37 CEREBELLAR TUMOUR 2 0.0159
38 FUSARIUM INFECTION 11 0.0157
39 ACUTE MYELOID LEUKAEMIA 242 0.0155
40 GRANULOCYTOSIS 3 0.0153
41 MYELOPROLIFERATIVE NEOPLASM 10 0.0151
42 ASPIRATION BONE MARROW 2 0.0150
43 CEREBRAL ASPERGILLOSIS 9 0.0146
44 RHINOCEREBRAL MUCORMYCOSIS 5 0.0144
45 IDIOPATHIC INTERSTITIAL PNEUMONIA 5 0.0141
46 HUMAN HERPESVIRUS 6 ENCEPHALITIS 4 0.0141
47 HYPERVISCOSITY SYNDROME 4 0.0139
48 ESCHERICHIA BACTERAEMIA 31 0.0132
49 LEUKAEMIA RECURRENT 22 0.0130
50 CHROMOSOMAL DELETION 2 0.0126
51 MINIMAL RESIDUAL DISEASE 6 0.0124
52 DIFFERENTIATION SYNDROME 9 0.0123
53 MYELOSUPPRESSION 438 0.0121
54 ANAL INFECTION 3 0.0117
55 CAECITIS 5 0.0111
56 ENTEROBACTER SEPSIS 4 0.0108
57 HAEMATOPOIETIC NEOPLASM 2 0.0106
58 BLAST CELLS PRESENT 5 0.0104
59 ACINETOBACTER TEST POSITIVE 2 0.0103
60 SINUSITIS FUNGAL 8 0.0100
61 ENTEROBACTER BACTERAEMIA 3 0.0099
62 MYELODYSPLASTIC SYNDROME TRANSFORMATION 5 0.0096
63 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 3 0.0096
64 BLAST CELL COUNT INCREASED 10 0.0095
65 STREPTOCOCCAL BACTERAEMIA 10 0.0092
66 PNEUMONIA FUNGAL 36 0.0091
67 NODULAR RASH 2 0.0090
68 MUCORMYCOSIS 23 0.0088
69 CHOROIDAL EFFUSION 7 0.0087
70 ALBUMIN GLOBULIN RATIO DECREASED 2 0.0086
71 SOFT TISSUE SARCOMA 3 0.0086
72 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 2 0.0086
73 ENGRAFTMENT SYNDROME 5 0.0085
74 CHRONIC GRAFT VERSUS HOST DISEASE 30 0.0083
75 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 2 0.0082
76 CHROMOSOME ANALYSIS ABNORMAL 2 0.0079
77 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 2 0.0078
78 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 11 0.0078
79 PLATELET TRANSFUSION 10 0.0078
80 INFESTATION 2 0.0077
81 LOWER RESPIRATORY TRACT INFECTION FUNGAL 3 0.0077
82 CULTURE WOUND POSITIVE 2 0.0077
83 GENE MUTATION 15 0.0076
84 ENTEROCOCCAL BACTERAEMIA 8 0.0075
85 CYTOKINE STORM 5 0.0073
86 GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0073
87 ATOPY 2 0.0072
88 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
89 TRANSPLANTATION COMPLICATION 3 0.0071
90 CHLOROMA 3 0.0071
91 PSEUDOMONAL BACTERAEMIA 6 0.0070
92 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
93 FEBRILE NEUTROPENIA 456 0.0069
94 CELLULITIS ORBITAL 4 0.0069
95 PSEUDOMONAL SEPSIS 12 0.0068
96 TERATOGENICITY 2 0.0066
97 BIOPSY BONE MARROW ABNORMAL 3 0.0066
98 ENTEROCOLITIS VIRAL 2 0.0066
99 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 15 0.0064
100 PULMONARY VASCULAR DISORDER 3 0.0064
101 NEUTROPENIC COLITIS 13 0.0063
102 MYELODYSPLASTIC SYNDROME 90 0.0062
103 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 4 0.0061
104 CARDIOACTIVE DRUG LEVEL INCREASED 8 0.0061
105 BLOOD OSMOLARITY INCREASED 2 0.0061
106 SOFT TISSUE INFECTION 11 0.0060
107 GROIN ABSCESS 7 0.0059
108 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 5 0.0059
109 BLOOD PRESSURE ORTHOSTATIC DECREASED 2 0.0059
110 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0058
111 PULMONARY MUCORMYCOSIS 3 0.0057
112 HAEMATOTOXICITY 54 0.0057
113 NON-CARDIOGENIC PULMONARY OEDEMA 6 0.0057
114 SCEDOSPORIUM INFECTION 4 0.0057
115 CANDIDA SEPSIS 5 0.0056
116 CYTOPENIA 67 0.0055
117 ENTEROCOLITIS INFECTIOUS 5 0.0054
118 PERIRECTAL ABSCESS 6 0.0054
119 BONE MARROW FAILURE 110 0.0054
120 SPINAL CORD OEDEMA 2 0.0054
121 BACTERAEMIA 62 0.0052
122 ASPERGILLUS INFECTION 34 0.0052
123 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 11 0.0052
124 DISSEMINATED MUCORMYCOSIS 2 0.0051
125 ENCEPHALITIS VIRAL 6 0.0049
126 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
127 GRANULOCYTE COUNT DECREASED 9 0.0048
128 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
129 FUNGAL SEPSIS 4 0.0048
130 BLOOD PRODUCT TRANSFUSION DEPENDENT 2 0.0048
131 BONE MARROW TRANSPLANT 9 0.0047
132 ORGANISING PNEUMONIA 23 0.0046
133 TRANSFUSION REACTION 4 0.0046
134 TUMOUR LYSIS SYNDROME 40 0.0045
135 SPUTUM ABNORMAL 3 0.0045
136 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 2 0.0045
137 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 5 0.0045
138 MALIGNANT TRANSFORMATION 2 0.0045
139 BLOOD LACTATE DEHYDROGENASE ABNORMAL 3 0.0044
140 ACUTE GRAFT VERSUS HOST DISEASE 20 0.0044
141 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0043
142 SYSTEMIC MYCOSIS 5 0.0043
143 BIOPSY BONE MARROW 2 0.0043
144 DISSEMINATED ASPERGILLOSIS 2 0.0042
145 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 16 0.0042
146 GRAFT VERSUS HOST DISEASE IN LUNG 2 0.0042
147 BRONCHIAL WALL THICKENING 3 0.0042
148 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
149 PNEUMONIA HAEMOPHILUS 2 0.0041
150 CYTOMEGALOVIRUS VIRAEMIA 18 0.0040
151 EOSINOPHIL COUNT ABNORMAL 3 0.0040
152 SYSTEMIC CANDIDA 10 0.0040
153 CALCULUS URINARY 6 0.0039
154 PULMONARY MYCOSIS 3 0.0039
155 FUNGAEMIA 6 0.0038
156 OBLITERATIVE BRONCHIOLITIS 5 0.0038
157 PNEUMONIA KLEBSIELLA 7 0.0038
158 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
159 PACKED RED BLOOD CELL TRANSFUSION 5 0.0038
160 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
161 VASCULAR DEVICE INFECTION 17 0.0037
162 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
163 ENTEROCOCCAL INFECTION 18 0.0037
164 STENOTROPHOMONAS INFECTION 5 0.0037
165 ACINETOBACTER INFECTION 4 0.0037
166 MYELOFIBROSIS 11 0.0036
167 EPSTEIN-BARR VIRAEMIA 4 0.0036
168 ENTEROBACTER INFECTION 6 0.0036
169 PNEUMONIA PRIMARY ATYPICAL 2 0.0036
170 KLEBSIELLA SEPSIS 4 0.0035
171 ENTEROVIRUS INFECTION 3 0.0035
172 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
173 FEBRILE INFECTION 4 0.0034
174 PSEUDOMONAS INFECTION 29 0.0034
175 RESPIRATORY TRACT HAEMORRHAGE 2 0.0034
176 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
177 MEAN PLATELET VOLUME INCREASED 2 0.0033
178 STEM CELL TRANSPLANT 8 0.0032
179 HYPERURICAEMIA 13 0.0032
180 KLEBSIELLA BACTERAEMIA 3 0.0032
181 NEUTROPENIC INFECTION 3 0.0031
182 ACTINOMYCOSIS 3 0.0031
183 ESCHERICHIA SEPSIS 9 0.0031
184 ACUTE LEUKAEMIA 5 0.0031
185 HYPERBILIRUBINAEMIA 32 0.0031
186 PROCEDURAL VOMITING 2 0.0031
187 THERAPY PARTIAL RESPONDER 48 0.0031
188 GRAFT VERSUS HOST DISEASE 22 0.0031
189 THROMBOCYTOSIS 11 0.0030
190 NEUTROPENIC SEPSIS 21 0.0029
191 MARROW HYPERPLASIA 2 0.0029
192 OESOPHAGITIS ULCERATIVE 2 0.0029
193 BRUGADA SYNDROME 3 0.0029
194 EPSTEIN-BARR VIRUS INFECTION 18 0.0029
195 PANCYTOPENIA 156 0.0028
196 MUCOSAL INFLAMMATION 73 0.0028
197 INVESTIGATION ABNORMAL 4 0.0028
198 ANGLE CLOSURE GLAUCOMA 7 0.0027
199 PHILADELPHIA CHROMOSOME POSITIVE 2 0.0027
200 CYSTITIS HAEMORRHAGIC 11 0.0027
201 LUNG INFECTION 42 0.0027
202 SERRATIA INFECTION 2 0.0027
203 MYOCARDIAL INJURY 3 0.0027
204 CYTOGENETIC ABNORMALITY 3 0.0027
205 GINGIVAL HYPERTROPHY 4 0.0026
206 HYPOPROTEINAEMIA 5 0.0026
207 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
208 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
209 CARBON DIOXIDE DECREASED 3 0.0026
210 THROMBOCYTOPENIA 291 0.0026
211 HYPOALBUMINAEMIA 20 0.0026
212 KLEBSIELLA INFECTION 13 0.0026
213 MYOPERICARDITIS 2 0.0026
214 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
215 MUSCLE DISCOMFORT 2 0.0025
216 HOSPICE CARE 25 0.0025
217 PRODUCT CONFUSION 2 0.0025
218 OESOPHAGEAL CANDIDIASIS 10 0.0025
219 ESCHERICHIA TEST POSITIVE 3 0.0025
220 SKIN BACTERIAL INFECTION 2 0.0025
221 ACUTE LYMPHOCYTIC LEUKAEMIA 7 0.0025
222 RESPIRATORY ALKALOSIS 4 0.0025
223 NEUTROPENIA 334 0.0025
224 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 3 0.0024
225 ADENOVIRUS INFECTION 7 0.0024
226 SYSTEMIC INFECTION 4 0.0024
227 HEPATOSPLENOMEGALY 6 0.0023
228 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
229 HYPOPITUITARISM 4 0.0023
230 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
231 HYPERLEUKOCYTOSIS 2 0.0023
232 FAECES PALE 5 0.0022
233 MUSCLE NECROSIS 2 0.0022
234 SELECTIVE EATING DISORDER 2 0.0022
235 BODY TEMPERATURE ABNORMAL 4 0.0022
236 VIRAEMIA 3 0.0022
237 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
238 NEUTROPHIL COUNT ABNORMAL 6 0.0021
239 FAILURE TO THRIVE 11 0.0021
240 DIABETES INSIPIDUS 5 0.0021
241 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
242 THERAPY NON-RESPONDER 93 0.0021
243 APLASIA 4 0.0020
244 HAEMOGLOBIN ABNORMAL 13 0.0020
245 SEPTIC SHOCK 87 0.0020
246 CATHETER SITE HAEMORRHAGE 5 0.0020
247 BONE MARROW DISORDER 6 0.0020
248 PLATELET DISORDER 5 0.0020
249 PNEUMONIA BACTERIAL 18 0.0020
250 STEROID WITHDRAWAL SYNDROME 2 0.0020
251 CAPILLARY LEAK SYNDROME 4 0.0019
252 CYTOGENETIC ANALYSIS ABNORMAL 2 0.0019
253 SINUSITIS BACTERIAL 2 0.0019
254 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
255 NON-CARDIAC CHEST PAIN 6 0.0019
256 HYPOPHOSPHATAEMIA 14 0.0019
257 HYPERPYREXIA 8 0.0019
258 SEPSIS 207 0.0019
259 IRON OVERLOAD 2 0.0019
260 SERUM SICKNESS 5 0.0018
261 NEUTROPHIL COUNT DECREASED 73 0.0018
262 GRANULOCYTOPENIA 10 0.0018
263 PULMONARY GRANULOMA 2 0.0018
264 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
265 HAEMORRHAGE INTRACRANIAL 26 0.0017
266 MUCOSAL HAEMORRHAGE 2 0.0017
267 PERIPHERAL SENSORY NEUROPATHY 10 0.0017
268 ERYTHEMA NODOSUM 6 0.0017
269 ARTHRITIS BACTERIAL 7 0.0017
270 PROCALCITONIN INCREASED 2 0.0017
271 STREPTOCOCCAL SEPSIS 2 0.0017
272 ATYPICAL PNEUMONIA 5 0.0017
273 BLOOD CULTURE POSITIVE 5 0.0017
274 ANAL ABSCESS 9 0.0017
275 DYSPLASIA 2 0.0017
276 CENTRAL VENOUS CATHETERISATION 5 0.0017
277 RESPIRATORY FAILURE 120 0.0016
278 HAEMATOLOGICAL INFECTION 4 0.0016
279 DISEASE PROGRESSION 192 0.0016
280 OTOTOXICITY 3 0.0016
281 OPPORTUNISTIC INFECTION 3 0.0016
282 CARDIAC DYSFUNCTION 6 0.0016
283 AORTIC VALVE REPLACEMENT 2 0.0016
284 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
285 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
286 WHITE BLOOD CELL COUNT ABNORMAL 10 0.0016
287 PROCTALGIA 10 0.0016
288 BACTERIAL INFECTION 29 0.0016
289 TRAUMATIC LUNG INJURY 3 0.0016
290 RHINOVIRUS INFECTION 6 0.0015
291 BACTERIAL SEPSIS 5 0.0015
292 PLATELET COUNT DECREASED 163 0.0015
293 DRUG RESISTANCE 39 0.0015
294 SERUM FERRITIN INCREASED 8 0.0015
295 SKIN INFECTION 17 0.0015
296 ANION GAP INCREASED 2 0.0015
297 LEUKOCYTOSIS 27 0.0015
298 DEVICE RELATED SEPSIS 3 0.0015
299 LEUKAEMIA 14 0.0015
300 ESCHERICHIA INFECTION 12 0.0015
301 AGRANULOCYTOSIS 27 0.0015
302 BLOOD CREATININE ABNORMAL 5 0.0014
303 ACIDOSIS 11 0.0014
304 TRANSFUSION 15 0.0014
305 CARDIOMYOPATHY 21 0.0014
306 INTENSIVE CARE 2 0.0014
307 ACUTE RESPIRATORY FAILURE 27 0.0014
308 FULL BLOOD COUNT DECREASED 28 0.0014
309 BLOOD COUNT ABNORMAL 21 0.0014
310 PULMONARY SEPSIS 2 0.0014
311 INFECTION SUSCEPTIBILITY INCREASED 3 0.0014
312 PULMONARY VALVE INCOMPETENCE 2 0.0014
313 MENTAL FATIGUE 2 0.0013
314 THROMBOTIC MICROANGIOPATHY 13 0.0013
315 GINGIVAL BLEEDING 18 0.0013
316 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
317 ECCHYMOSIS 9 0.0013
318 METASTATIC MALIGNANT MELANOMA 3 0.0013
319 CYTOMEGALOVIRUS COLITIS 3 0.0013
320 OLIGURIA 8 0.0013
321 BILIRUBIN CONJUGATED INCREASED 3 0.0013
322 CARDIOPULMONARY FAILURE 5 0.0013
323 PULMONARY HAEMORRHAGE 10 0.0013
324 PULMONARY TOXICITY 9 0.0013
325 PUSTULE 3 0.0013
326 URINARY TRACT OBSTRUCTION 3 0.0013
327 AZOTAEMIA 5 0.0013
328 INFECTION 181 0.0012
329 WHITE BLOOD CELL COUNT DECREASED 135 0.0012
330 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
331 PAPILLOMA VIRAL INFECTION 2 0.0012
332 MULTIPLE ORGAN DYSFUNCTION SYNDROME 34 0.0012
333 VENOOCCLUSIVE DISEASE 3 0.0012
334 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
335 MALIGNANT PLEURAL EFFUSION 2 0.0012
336 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
337 CLOSTRIDIAL INFECTION 4 0.0012
338 SPLEEN DISORDER 2 0.0012
339 NEOPLASM RECURRENCE 4 0.0012
340 PHLEBITIS 6 0.0012
341 DEVICE RELATED INFECTION 18 0.0012
342 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
343 PLATELET COUNT ABNORMAL 7 0.0012
344 BLOOD CHLORIDE INCREASED 2 0.0012
345 PETECHIAE 12 0.0011
346 ANAEMIA 218 0.0011
347 BRONCHIOLITIS 4 0.0011
348 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
349 LUNG INFILTRATION 10 0.0011
350 GASTROINTESTINAL OEDEMA 2 0.0011
351 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
352 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
353 RED BLOOD CELL COUNT DECREASED 32 0.0011
354 ELECTROLYTE IMBALANCE 13 0.0011
355 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
356 GASTROINTESTINAL INJURY 3 0.0011
357 FUNGAL INFECTION 37 0.0011
358 SPLENOMEGALY 13 0.0011
359 SHOCK HAEMORRHAGIC 9 0.0011
360 MONOCYTE COUNT INCREASED 4 0.0011
361 SUBDURAL HAEMORRHAGE 3 0.0011
362 LOBAR PNEUMONIA 2 0.0011
363 LUNG CONSOLIDATION 3 0.0011
364 ANAL HAEMORRHAGE 3 0.0011
365 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
366 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
367 PNEUMONITIS 29 0.0011
368 NECK MASS 3 0.0011
369 CHEMOTHERAPY 4 0.0011
370 NEUTROPHILIA 6 0.0011
371 ILEUS 13 0.0010
372 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
373 GASTROINTESTINAL TOXICITY 5 0.0010
374 ENTEROCOLITIS 6 0.0010
375 NEOPLASM PROGRESSION 36 0.0010
376 ATRIOVENTRICULAR BLOCK 8 0.0010
377 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
378 EARLY SATIETY 2 0.0010
379 PURULENCE 2 0.0010
380 HYPOXIA 36 0.0010
381 HYPOGEUSIA 2 0.0010
382 BICYTOPENIA 2 0.0010
383 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
384 BREATH SOUNDS ABNORMAL 5 0.0010
385 HYPERVOLAEMIA 5 0.0010
386 BLOOD ALBUMIN DECREASED 8 0.0010
387 EMPYEMA 2 0.0010
388 GASTROINTESTINAL INFECTION 9 0.0010
389 PNEUMONIA 325 0.0010
390 BLOOD BILIRUBIN INCREASED 27 0.0010
391 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
393 HAEMOGLOBIN DECREASED 101 0.0010
394 TOOTH ABSCESS 10 0.0010
395 INTRACARDIAC THROMBUS 3 0.0010
396 VENTRICULAR TACHYCARDIA 16 0.0010
397 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
398 DISEASE RECURRENCE 46 0.0010
399 EMBOLISM 8 0.0010
400 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
401 MOUTH HAEMORRHAGE 7 0.0010
402 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
403 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
404 LIVER INJURY 23 0.0009
405 SPUTUM INCREASED 2 0.0009
406 TROPONIN INCREASED 7 0.0009
407 LYMPHOCYTE COUNT INCREASED 3 0.0009
408 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
409 CLOSTRIDIUM TEST POSITIVE 2 0.0009
410 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
411 HYPOPHAGIA 23 0.0009
412 HYPOCALCAEMIA 17 0.0009
413 TEMPERATURE REGULATION DISORDER 2 0.0009
414 BACTERIAL TEST POSITIVE 2 0.0009
415 CANDIDA INFECTION 15 0.0009
416 BLOOD LOSS ANAEMIA 2 0.0009
417 PRODUCT USE IN UNAPPROVED INDICATION 218 0.0009
418 BRONCHOPNEUMONIA 3 0.0009
419 CARDIAC FAILURE 70 0.0009
420 HAEMANGIOMA 2 0.0009
421 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
422 HYPOMAGNESAEMIA 12 0.0009
423 BLOOD TEST ABNORMAL 12 0.0009
424 NECROTISING FASCIITIS 3 0.0009
425 LYMPHOCYTE COUNT DECREASED 15 0.0008
426 COLORECTAL CANCER METASTATIC 2 0.0008
427 TRANSPLANT 2 0.0008
428 CARDIAC TAMPONADE 4 0.0008
429 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
430 SUBDURAL HAEMATOMA 12 0.0008
431 DRUG-INDUCED LIVER INJURY 26 0.0008
432 PANNICULITIS 2 0.0008
433 LYMPHADENITIS 2 0.0008
434 PRODUCT PACKAGING CONFUSION 2 0.0008
435 COLITIS 31 0.0008
436 ANURIA 7 0.0008
437 INFLAMMATORY MARKER INCREASED 4 0.0008
438 IMMUNODEFICIENCY 12 0.0008
439 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
440 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
441 PROTEIN TOTAL DECREASED 3 0.0008
442 BRAIN ABSCESS 2 0.0008
443 TOXIC ENCEPHALOPATHY 4 0.0008
444 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
445 BODY TEMPERATURE INCREASED 16 0.0008
446 BOWEL MOVEMENT IRREGULARITY 6 0.0008
447 ABDOMINAL INFECTION 2 0.0008
448 NOCARDIOSIS 2 0.0008
449 MALIGNANT NEOPLASM PROGRESSION 80 0.0008
450 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
451 ENDOCARDITIS 4 0.0008
452 LEUKOPENIA 39 0.0008
453 HERPES SIMPLEX 5 0.0008
454 ORAL INFECTION 3 0.0008
455 PLATELET COUNT INCREASED 10 0.0008
456 HYPERSENSITIVITY VASCULITIS 2 0.0008
457 PYREXIA 263 0.0008
458 MOUTH ULCERATION 16 0.0008
459 BLOOD LACTIC ACID INCREASED 4 0.0008
460 STAPHYLOCOCCAL INFECTION 25 0.0008
461 FURUNCLE 6 0.0008
462 APPENDICITIS 7 0.0007
463 ORGAN FAILURE 3 0.0007
464 RECURRENT CANCER 3 0.0007
465 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
466 ATELECTASIS 7 0.0007
467 SECOND PRIMARY MALIGNANCY 6 0.0007
468 DRUG TOLERANCE DECREASED 2 0.0007
469 MUSCLE FATIGUE 3 0.0007
470 FEBRILE BONE MARROW APLASIA 3 0.0007
471 HEPATIC PAIN 3 0.0007
472 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
473 HEPATIC FUNCTION ABNORMAL 26 0.0007
474 BLOOD URIC ACID INCREASED 4 0.0007
475 RALES 4 0.0007
476 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
477 PLEURAL EFFUSION 41 0.0007
478 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
479 ILEUS PARALYTIC 3 0.0007
480 PULMONARY OEDEMA 30 0.0007
481 PROTHROMBIN TIME PROLONGED 4 0.0007
482 HAEMORRHOIDS 13 0.0007
483 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
484 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
485 HAEMODYNAMIC INSTABILITY 5 0.0007
486 NO THERAPEUTIC RESPONSE 8 0.0007
487 HAEMATOCRIT DECREASED 13 0.0007
488 DISEASE COMPLICATION 3 0.0007
489 CHEST X-RAY ABNORMAL 2 0.0007
490 CHRONIC MYELOID LEUKAEMIA 3 0.0006
491 MENTAL STATUS CHANGES 18 0.0006
492 CYTOKINE RELEASE SYNDROME 13 0.0006
493 MELAENA 14 0.0006
494 SINUS TACHYCARDIA 9 0.0006
495 HEPATOTOXICITY 14 0.0006
496 PNEUMONIA VIRAL 2 0.0006
497 SUBCUTANEOUS ABSCESS 3 0.0006
498 PORTAL VEIN THROMBOSIS 2 0.0006
499 LIVER ABSCESS 2 0.0006
500 RENAL TUBULAR NECROSIS 6 0.0006
501 BREAST ENLARGEMENT 2 0.0006
502 HYPOKALAEMIA 28 0.0006
503 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
504 PERICARDITIS 10 0.0006
505 TONGUE ULCERATION 2 0.0006
506 B-CELL LYMPHOMA 2 0.0006
507 ALANINE AMINOTRANSFERASE INCREASED 36 0.0006
508 OFF LABEL USE 508 0.0006
509 MULTI-ORGAN FAILURE 10 0.0006
510 GRANULOMA 2 0.0006
511 HYPERTRANSAMINASAEMIA 4 0.0006
512 THROMBOPHLEBITIS 2 0.0006
513 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
514 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
515 TOOTH EXTRACTION 7 0.0006
516 RETINAL HAEMORRHAGE 4 0.0006
517 APPENDICECTOMY 2 0.0006
518 PNEUMONIA ASPIRATION 14 0.0006
519 GINGIVITIS 3 0.0006
520 PYODERMA GANGRENOSUM 2 0.0006
521 CELLULITIS 28 0.0006
522 PATHOGEN RESISTANCE 5 0.0005
523 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
524 HYPERKERATOSIS 3 0.0005
525 CYTOMEGALOVIRUS INFECTION 9 0.0005
526 MEDICAL DEVICE COMPLICATION 4 0.0005
527 STREPTOCOCCAL INFECTION 3 0.0005
528 LEUKOENCEPHALOPATHY 2 0.0005
529 TOOTH INFECTION 7 0.0005
530 SKIN TOXICITY 3 0.0005
531 MYOCARDITIS 6 0.0005
532 HERPES VIRUS INFECTION 3 0.0005
533 OESOPHAGEAL ULCER 2 0.0005
534 REHABILITATION THERAPY 2 0.0005
535 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
536 ATRIAL FIBRILLATION 50 0.0005
537 EPIGASTRIC DISCOMFORT 2 0.0005
538 RESPIRATORY ACIDOSIS 2 0.0005
539 ACUTE MYOCARDIAL INFARCTION 15 0.0005
540 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
541 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
542 ATRIAL FLUTTER 4 0.0005
543 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
544 BLEPHARITIS 2 0.0005
545 MUSCLE HAEMORRHAGE 2 0.0005
546 RHINITIS 4 0.0005
547 BLOOD POTASSIUM INCREASED 8 0.0005
548 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
549 PERIPHERAL ISCHAEMIA 2 0.0005
550 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
551 EXTRAVASATION 2 0.0005
552 ACUTE CORONARY SYNDROME 4 0.0005
553 FLUID OVERLOAD 7 0.0005
554 PERICARDIAL EFFUSION 11 0.0005
555 FULL BLOOD COUNT ABNORMAL 5 0.0005
556 BUNDLE BRANCH BLOCK LEFT 2 0.0005
557 RENAL FAILURE ACUTE 20 0.0005
558 TREATMENT FAILURE 39 0.0005
559 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
560 DIVERTICULITIS 13 0.0005
561 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
562 HEPATIC LESION 2 0.0005
563 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
564 DELIRIUM 16 0.0005
565 ORTHOSTATIC HYPOTENSION 8 0.0005
566 IMMUNOSUPPRESSION 4 0.0005
567 GINGIVAL SWELLING 2 0.0005
568 CARDIAC FAILURE ACUTE 3 0.0004
569 VENTRICULAR FIBRILLATION 5 0.0004
570 MALNUTRITION 5 0.0004
571 THERAPEUTIC RESPONSE DECREASED 27 0.0004
572 BLOOD CALCIUM DECREASED 5 0.0004
573 TACHYPNOEA 6 0.0004
574 IMMUNE THROMBOCYTOPENIA 2 0.0004
575 ISCHAEMIA 2 0.0004
576 RESPIRATORY DISTRESS 12 0.0004
577 UROSEPSIS 4 0.0004
578 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
579 HEPATIC FAILURE 13 0.0004
580 VASCULITIS 5 0.0004
581 STOMATITIS 26 0.0004
582 PERFORMANCE STATUS DECREASED 2 0.0004
583 DUODENAL ULCER 3 0.0004
584 HAEMATOMA 11 0.0004
585 SKIN ABRASION 2 0.0004
586 RESPIRATORY TRACT INFECTION 11 0.0004
587 BRONCHOSPASM 6 0.0004
588 METASTASIS 3 0.0004
589 DIABETIC KETOACIDOSIS 10 0.0004
590 APHAGIA 2 0.0004
591 SINUS BRADYCARDIA 4 0.0004
592 DIZZINESS POSTURAL 4 0.0004
593 CARDIAC ARREST 34 0.0004
594 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
595 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
596 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
597 STAPHYLOCOCCAL SEPSIS 2 0.0004
598 GENERALISED OEDEMA 5 0.0004
599 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
600 PULMONARY MASS 6 0.0004
601 SUNBURN 3 0.0004
602 GASTROINTESTINAL DISORDER 36 0.0004
603 ANEURYSM 2 0.0004
604 DYSPHORIA 2 0.0004
605 SUBARACHNOID HAEMORRHAGE 4 0.0004
606 INTERSTITIAL LUNG DISEASE 19 0.0004
607 CEREBRAL HAEMORRHAGE 14 0.0004
608 NEUTROPHIL COUNT INCREASED 4 0.0004
609 RENAL FAILURE CHRONIC 3 0.0004
610 CACHEXIA 2 0.0004
611 APHTHOUS ULCER 3 0.0004
612 PULMONARY HYPERTENSION 8 0.0004
613 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
614 GINGIVAL PAIN 3 0.0004
615 ABSCESS 6 0.0004
616 BLOOD DISORDER 3 0.0004
617 HYPONATRAEMIA 21 0.0004
618 ACUTE KIDNEY INJURY 57 0.0004
619 PRESYNCOPE 9 0.0004
620 ASPIRATION 4 0.0004
621 ASTHENOPIA 2 0.0004
622 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
623 PRODUCT USE ISSUE 68 0.0004
624 EPISTAXIS 27 0.0004
625 COAGULOPATHY 6 0.0004
626 NECROSIS 2 0.0004
627 ORAL PAIN 8 0.0004
628 HAEMATEMESIS 9 0.0004
629 CHOLECYSTITIS ACUTE 2 0.0004
630 SKIN ULCER 9 0.0003
631 SHOCK 8 0.0003
632 PRODUCT LABEL CONFUSION 2 0.0003
633 HYPOTENSION 68 0.0003
634 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
635 CARDIAC PACEMAKER INSERTION 2 0.0003
636 ODYNOPHAGIA 2 0.0003
637 HAEMORRHAGE 35 0.0003
638 ANAL INCONTINENCE 3 0.0003
639 DEATH 287 0.0003
640 LOCALISED INFECTION 8 0.0003
641 HYPERGLYCAEMIA 12 0.0003
642 END STAGE RENAL DISEASE 6 0.0003
643 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
644 DYSURIA 12 0.0003
645 CARDIOMEGALY 4 0.0003
646 ASTHENIA 122 0.0003
647 OSTEONECROSIS OF JAW 8 0.0003
648 CHOLANGITIS 2 0.0003
649 EJECTION FRACTION DECREASED 5 0.0003
650 CONSTIPATION 70 0.0003
651 PRE-EXISTING CONDITION IMPROVED 2 0.0003
652 FLANK PAIN 3 0.0003
653 NASAL DRYNESS 2 0.0003
654 BLOOD PRESSURE DECREASED 21 0.0003
655 TRANSAMINASES INCREASED 7 0.0003
656 ENTERITIS 2 0.0003
657 MYDRIASIS 4 0.0003
658 CARDIO-RESPIRATORY ARREST 13 0.0003
659 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
660 AUTOIMMUNE DISORDER 3 0.0003
661 CHILLS 36 0.0003
662 BLOOD CREATININE INCREASED 20 0.0003
663 HEPATOMEGALY 3 0.0003
664 LABORATORY TEST ABNORMAL 9 0.0003
665 ORAL CANDIDIASIS 4 0.0003
666 BLOOD POTASSIUM DECREASED 9 0.0003
667 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
668 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
669 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
670 NEPHROTIC SYNDROME 2 0.0003
671 DECREASED APPETITE 67 0.0003
672 LARGE INTESTINE PERFORATION 2 0.0003
673 HAEMOPTYSIS 8 0.0003
674 NEUROTOXICITY 5 0.0003
675 URINARY TRACT INFECTION 48 0.0003
676 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
677 LACTIC ACIDOSIS 9 0.0003
678 DEEP VEIN THROMBOSIS 18 0.0003
679 FAECES DISCOLOURED 6 0.0003
680 TONGUE DISORDER 2 0.0003
681 SKIN LACERATION 3 0.0003
682 LIVER FUNCTION TEST ABNORMAL 8 0.0003
683 GASTROENTERITIS 4 0.0003
684 GASTROINTESTINAL PAIN 3 0.0003
685 URINARY RETENTION 9 0.0003
686 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
687 FISTULA 3 0.0003
688 GASTRITIS 7 0.0003
689 DRUG INEFFECTIVE 349 0.0003
690 RENAL FAILURE 35 0.0003
691 MUSCULOSKELETAL CHEST PAIN 4 0.0003
692 SKIN LESION 7 0.0003
693 OEDEMA PERIPHERAL 31 0.0003
694 RENAL CYST 2 0.0003
695 HYPERLIPIDAEMIA 3 0.0003
696 POLYNEUROPATHY 3 0.0003
697 NIGHT SWEATS 8 0.0002
698 LIVER DISORDER 11 0.0002
699 POST PROCEDURAL INFECTION 2 0.0002
700 DECUBITUS ULCER 2 0.0002
701 ENCEPHALOPATHY 6 0.0002
702 SMALL INTESTINAL OBSTRUCTION 3 0.0002
703 HYPERCALCAEMIA 3 0.0002
704 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
705 PHARYNGITIS 3 0.0002
706 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
707 BLOOD UREA INCREASED 4 0.0002
708 FACE OEDEMA 4 0.0002
709 MUSCLE ATROPHY 3 0.0002
710 RENAL INJURY 7 0.0002
711 RESPIRATORY DISORDER 7 0.0002
712 HAEMATURIA 8 0.0002
713 SKIN HYPERPIGMENTATION 2 0.0002
714 NAUSEA 183 0.0002
715 CARDIAC MURMUR 2 0.0002
716 PURPURA 2 0.0002
717 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
718 RESPIRATORY RATE INCREASED 2 0.0002
719 NERVOUS SYSTEM DISORDER 7 0.0002
720 DYSPEPSIA 22 0.0002
721 OROPHARYNGEAL DISCOMFORT 2 0.0002
722 OEDEMA 12 0.0002
723 HEPATIC ENZYME INCREASED 15 0.0002
724 ACUTE HEPATIC FAILURE 3 0.0002
725 METABOLIC ACIDOSIS 7 0.0002
726 BRAIN NEOPLASM 2 0.0002
727 RESPIRATORY ARREST 6 0.0002
728 IRON DEFICIENCY ANAEMIA 2 0.0002
729 CONFUSIONAL STATE 35 0.0002
730 NECK PAIN 12 0.0002
731 HEPATIC ENCEPHALOPATHY 2 0.0002
732 DYSPNOEA 121 0.0002
733 INTESTINAL OBSTRUCTION 8 0.0002
734 DIARRHOEA 137 0.0002
735 BLOOD SODIUM DECREASED 4 0.0002
736 UNEVALUABLE EVENT 16 0.0002
737 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
738 DYSPHAGIA 20 0.0002
739 GASTRIC ULCER 4 0.0002
740 PRODUCTIVE COUGH 10 0.0002
741 CARDIOGENIC SHOCK 3 0.0002
742 CHOLESTASIS 4 0.0002
743 DRUG INTERACTION 33 0.0002
744 BRADYCARDIA 11 0.0002
745 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
746 HYPERCHOLESTEROLAEMIA 2 0.0002
747 OROPHARYNGEAL PAIN 19 0.0002
748 ORAL HERPES 4 0.0002
749 RENAL IMPAIRMENT 17 0.0002
750 SKIN DISCOLOURATION 9 0.0002
751 OXYGEN SATURATION DECREASED 11 0.0002
752 TOXICITY TO VARIOUS AGENTS 33 0.0002
753 DEHYDRATION 26 0.0002
754 TEMPERATURE INTOLERANCE 2 0.0002
755 ABDOMINAL PAIN 45 0.0002
756 EYE DISCHARGE 2 0.0002
757 TENDERNESS 2 0.0002
758 PRODUCT USE COMPLAINT 3 0.0002
759 PNEUMOTHORAX 3 0.0002
760 SUDDEN DEATH 2 0.0002
761 ULCER 3 0.0002
762 EATING DISORDER 4 0.0002
763 VOMITING 88 0.0002
764 CARDIAC FAILURE CONGESTIVE 15 0.0002
765 DYSPNOEA EXERTIONAL 7 0.0002
766 DECREASED ACTIVITY 2 0.0002
767 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
768 CHOLELITHIASIS 6 0.0002
769 HOSPITALISATION 28 0.0002
770 ABDOMINAL DISTENSION 19 0.0002
771 PHOTOSENSITIVITY REACTION 3 0.0002
772 VIRAL INFECTION 6 0.0002
773 PROCEDURAL PAIN 5 0.0002
774 RASH MACULO-PAPULAR 4 0.0002
775 DEMENTIA 5 0.0002
776 FATIGUE 139 0.0002
777 OCULAR DISCOMFORT 2 0.0002
778 MITRAL VALVE INCOMPETENCE 2 0.0002
779 COVID-19 31 0.0002
780 CIRCULATORY COLLAPSE 3 0.0002
781 MUSCULAR WEAKNESS 20 0.0002
782 MYOCARDIAL ISCHAEMIA 2 0.0002
783 INTERNAL HAEMORRHAGE 2 0.0002
784 COUGH 49 0.0002
785 LETHARGY 10 0.0002
786 MUSCULOSKELETAL PAIN 9 0.0002
787 RASH MACULAR 6 0.0002
788 COVID-19 PNEUMONIA 2 0.0002
789 TACHYCARDIA 15 0.0002
790 PULMONARY EMBOLISM 16 0.0002
791 MACULAR DEGENERATION 2 0.0002
792 RASH ERYTHEMATOUS 8 0.0002
793 TOOTHACHE 3 0.0002
794 HEPATITIS C 2 0.0002
795 DRUG INTOLERANCE 16 0.0002
796 APHASIA 5 0.0002
797 NEOPLASM MALIGNANT 11 0.0002
798 NOCTURIA 2 0.0002
799 CEREBRAL INFARCTION 4 0.0002
800 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
801 NEUROPATHY PERIPHERAL 15 0.0002
802 PULMONARY FIBROSIS 3 0.0002
803 CHEST DISCOMFORT 16 0.0002
804 CHOKING 3 0.0002
805 ANKYLOSING SPONDYLITIS 2 0.0002
806 BLOOD PRESSURE ABNORMAL 3 0.0002
807 SYNCOPE 15 0.0001
808 EYE HAEMORRHAGE 2 0.0001
809 MALIGNANT MELANOMA 2 0.0001
810 QUALITY OF LIFE DECREASED 2 0.0001
811 SINUS CONGESTION 2 0.0001
812 TASTE DISORDER 3 0.0001
813 SKIN REACTION 2 0.0001
814 OSTEOARTHRITIS 6 0.0001
815 CONDITION AGGRAVATED 43 0.0001
816 LYMPHOPENIA 2 0.0001
817 DIALYSIS 2 0.0001
818 LIVER FUNCTION TEST INCREASED 3 0.0001
819 FLUID RETENTION 7 0.0001
820 SINUSITIS 14 0.0001
821 APPLICATION SITE PAIN 3 0.0001
822 ASCITES 4 0.0001
823 CONTUSION 13 0.0001
824 CHEST PAIN 25 0.0001
825 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
826 SKIN HAEMORRHAGE 2 0.0001
827 PANCREATITIS ACUTE 3 0.0001
828 CORONARY ARTERY DISEASE 4 0.0001
829 HEAD INJURY 4 0.0001
830 FALL 42 0.0001
831 OBESITY 2 0.0001
832 HIP FRACTURE 4 0.0001
833 RHINORRHOEA 8 0.0001
834 NEURALGIA 3 0.0001
835 SWELLING FACE 8 0.0001
836 BACK PAIN 28 0.0001
837 GAIT INABILITY 4 0.0001
838 RECTAL HAEMORRHAGE 5 0.0001
839 VAGINAL HAEMORRHAGE 5 0.0001
840 PRODUCT STORAGE ERROR 10 0.0001
841 HYPERKALAEMIA 4 0.0001
842 COLD SWEAT 2 0.0001
843 LYMPHADENOPATHY 4 0.0001
844 DRUG ERUPTION 2 0.0001
845 RASH 49 0.0001
846 GALLBLADDER DISORDER 2 0.0001
847 THIRST 2 0.0001
848 RASH PRURITIC 6 0.0001
849 OSTEOMYELITIS 2 0.0001
850 PERIPHERAL SWELLING 17 0.0001
851 PELVIC PAIN 2 0.0001
852 C-REACTIVE PROTEIN INCREASED 4 0.0001
853 AGITATION 8 0.0001
854 HAEMATOCHEZIA 6 0.0001
855 DIZZINESS 54 0.0001
856 CONJUNCTIVITIS 2 0.0001
857 FEELING COLD 3 0.0001
858 EYE SWELLING 4 0.0001
859 HEPATIC STEATOSIS 2 0.0001
860 PHOTOPHOBIA 2 0.0001
861 FRACTURE 2 0.0001
862 ARRHYTHMIA 5 0.0001
863 HERPES ZOSTER 6 0.0001
864 POST PROCEDURAL COMPLICATION 2 0.0001
865 SEIZURE 12 0.0001
866 HERNIA 2 0.0001
867 ERUCTATION 2 0.0001
868 HYPOGLYCAEMIA 5 0.0001
869 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
870 PLASMA CELL MYELOMA 4 0.0001
871 LUNG DISORDER 5 0.0001
872 URINARY INCONTINENCE 3 0.0001
873 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
874 CATARACT 6 0.0001
875 ADVERSE DRUG REACTION 9 0.0001
876 THROMBOSIS 8 0.0001
877 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
878 LACRIMATION INCREASED 3 0.0001
879 DERMATITIS 2 0.0001
880 HALLUCINATION, VISUAL 2 0.0001
881 DEPRESSED MOOD 5 0.0001
882 HYPERTENSION 20 0.0001
883 RETCHING 2 0.0001
884 LOSS OF CONSCIOUSNESS 12 0.0001
885 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
886 RASH PAPULAR 2 0.0001
887 SNEEZING 2 0.0001
888 MYALGIA 15 0.0001
889 ABDOMINAL DISCOMFORT 14 0.0001
890 BLOOD PRESSURE FLUCTUATION 2 0.0001
891 PAIN IN EXTREMITY 24 0.0001
892 INFLUENZA 9 0.0001
893 HALLUCINATION 6 0.0001
894 SOMNOLENCE 16 0.0001
895 CARDIOVASCULAR DISORDER 2 0.0001
896 HEPATITIS 2 0.0001
897 ILLNESS 8 0.0001
898 PALPITATIONS 9 0.0001
899 WEIGHT DECREASED 21 0.0001
900 MYOCARDIAL INFARCTION 13 0.0001
901 JAUNDICE 2 0.0001
902 FREQUENT BOWEL MOVEMENTS 2 0.0001
903 DRY MOUTH 6 0.0001
904 PALLOR 2 0.0001
905 HYPOAESTHESIA 11 0.0001
906 VISUAL IMPAIRMENT 9 0.0001
907 POLLAKIURIA 3 0.0001
908 ALOPECIA 14 0.0001
909 CEREBROVASCULAR ACCIDENT 12 0.0001
910 ANGINA PECTORIS 2 0.0001
911 HYPOACUSIS 3 0.0001
912 BONE PAIN 4 0.0001
913 ABDOMINAL PAIN UPPER 14 0.0001
914 PSYCHOTIC DISORDER 2 0.0001
915 PRURITUS 26 0.0001
916 WHEEZING 4 0.0001
917 DEPRESSION 15 0.0001
918 NASOPHARYNGITIS 12 0.0001
919 ARTHRALGIA 27 0.0001
920 RENAL DISORDER 3 0.0001
921 CARDIAC DISORDER 6 0.0001
922 CYSTITIS 2 0.0001
923 HYPOTHYROIDISM 2 0.0001
924 MALAISE 27 0.0001
925 IMPAIRED HEALING 2 0.0001
926 EYE DISORDER 2 0.0001
927 INFUSION RELATED REACTION 4 0.0001
928 PAIN 37 0.0001
929 SKIN EXFOLIATION 5 0.0001
930 INFLAMMATION 3 0.0001
931 BALANCE DISORDER 5 0.0001
932 GAIT DISTURBANCE 11 0.0001
933 HEART RATE DECREASED 2 0.0001
934 MOBILITY DECREASED 4 0.0001
935 ADVERSE EVENT 5 0.0001
936 HEADACHE 34 0.0001
937 TREMOR 9 0.0001
938 BRONCHITIS 4 0.0001
939 EYE IRRITATION 3 0.0001
940 DYSPHONIA 3 0.0001
941 SURGERY 3 0.0001
942 ARTHRITIS 4 0.0001
943 DISORIENTATION 2 0.0001
944 HEART RATE INCREASED 5 0.0001
945 JOINT SWELLING 6 0.0000
946 DISCOMFORT 3 0.0000
947 WEIGHT INCREASED 11 0.0000
948 BLOOD GLUCOSE INCREASED 9 0.0000
949 INSOMNIA 12 0.0000
950 PARAESTHESIA 7 0.0000
951 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
952 INCORRECT DOSE ADMINISTERED 10 0.0000
953 ERYTHEMA 9 0.0000
954 VISION BLURRED 6 0.0000
955 NEPHROLITHIASIS 2 0.0000
956 TINNITUS 2 0.0000
957 HYPERSENSITIVITY 8 0.0000
958 COGNITIVE DISORDER 2 0.0000
959 COMA 2 0.0000
960 THERAPY INTERRUPTED 3 0.0000
961 URTICARIA 7 0.0000
962 BLOOD GLUCOSE DECREASED 2 0.0000
963 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
964 BLOOD PRESSURE INCREASED 6 0.0000
965 HYPERHIDROSIS 5 0.0000
966 NERVOUSNESS 2 0.0000
967 MUSCLE SPASMS 7 0.0000
968 PANCREATITIS 2 0.0000
969 FEELING ABNORMAL 9 0.0000
970 ANAPHYLACTIC REACTION 2 0.0000
971 ANXIETY 10 0.0000
972 FEELING HOT 2 0.0000
973 SWELLING 3 0.0000
974 AMNESIA 2 0.0000
975 DRUG DOSE OMISSION 5 0.0000
976 MEMORY IMPAIRMENT 4 0.0000
977 INJECTION SITE REACTION 2 0.0000
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
979 ASTHMA 3 0.0000
980 HOT FLUSH 2 0.0000
981 CHRONIC KIDNEY DISEASE 2 0.0000
982 DIABETES MELLITUS 2 0.0000
983 PROSTATE CANCER 2 0.0000
984 EMOTIONAL DISTRESS 3 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
986 PSORIASIS 3 0.0000
987 INTENTIONAL PRODUCT MISUSE 2 0.0000
988 MUSCULOSKELETAL STIFFNESS 2 0.0000
989 DRY SKIN 3 0.0000
990 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
991 NO ADVERSE EVENT 4 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
993 OVERDOSE 2 0.0000
994 PRODUCT DOSE OMISSION ISSUE 2 0.0000